Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Hiring Campaign Continues; Goal Is Addressing Pending ANDAs

Sep 27 2016

• By Derrick Gingery

FDA entrance sign 2016

Related Content

Generics REMS Hurdles Lowered Somewhat By FDA Protocol Letters

Dec 04 2014

ANDA Approval Speed-Up Leaves Sponsors With Less Margin For Error

May 30 2016

EpiPen Generics: Woodcock Explains Injector Studies

Sep 22 2016

Scrutiny Of EpiPen Pricing Invited By Mylan Lobbying, Congressman Says

Sep 22 2016

FDA’s Generic Drug Staff To Be Reduced When Workload Under Control

Jan 20 2015

REMS And Generics: GPhA Needs Legislation, Continues Education

Aug 04 2014

REMS Abuse Legislation: GPhA and PhRMA Set To Battle Again

Jun 16 2016

ANDA Approvals, Submissions Decline With New Review Goal Coming

Aug 12 2016

ANDAs Can Get Priority, Eight-Month Reviews Under User Fee Deal

Sep 24 2016

Related Companies

Viatris Inc.

Additional Topics

United States Pricing Debate Drug Review Executive Changes Review Pathway Regulation BioPharmaceutical

More from Pricing Debate

More from Market Access

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window